| Health / Medical Topics |
AML mRNA Positive Lysate Loaded Autologous Dendritic Cell Vaccine
A cancer vaccine consisting of autologous dendritic cells loaded with separate preparations of acute myelogenous leukemia (AML) cell lysate and AML-specific messenger RNA (mRNA) with potential immunostimulatory and antineoplastic activities. Upon administration, AML mRNA plus lysate loaded autologous dendritic cell vaccine may elicit a potent cytotoxic T-cell (CTL) response against AML cells, resulting in tumor cell death. Autologous dendritic cells doubly-loaded with AML cell lysate and AML-specific mRNA may elicit superior primary, recall, and effector lytic immune responses compared to autologous dendritic cells loaded with tumor lysate or tumor mRNA alone. (NCI Thesaurus)
YOU MAY ALSO LIKE
An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone…
A colorless, odorless crystalline, aromatic amine with a bitter taste. Amitrole is a widely used herbicide for nonfood croplands to control annual…
A drug that is used to treat depression and may be given to treat anxiety, sleep disorders, and pain. It is also…
A drug that is used to treat depression and may be given to treat anxiety, sleep disorders, and pain. It is also…
An inhibitor of inosine monophosphate dehydrogenase with activity against several influenza A and B viruses. Amitivir inhibits the conversion of inosine monophosphate…
A thiosemicarbazone antimycobacterial agent with activity against isoniazid-resistant strains of Mycobacterium tuberculosis.
